Oncology journals

Best Oncology Journals: Impact Factors and Cancer Research Guide

Compare leading oncology and cancer research journals by impact factor, quartile, publisher, open-access status, and scope. Find journals for clinical trials, biomarkers, tumor biology, and cancer outcomes.

MZ
Dr. Meng Zhao|Physician-Scientist · Founder, LabCat AI
Published: June 2026Updated: June 11, 202612 min readField Rankings

Oncology publishing includes practice-changing clinical trials, translational biomarkers, tumor biology, population science, survivorship, and implementation research. Journal fit depends heavily on cancer type, development stage, clinical relevance, and whether the central result is mechanistic or patient-facing.

The list below combines journals classified in oncology and cancer research and ranks them using current Journal Metrics records. Review journals and primary-research journals can have very different citation patterns, so their impact factors should not be interpreted as directly equivalent.

About this ranking

Impact factors update annually and are only one part of journal selection. This page uses the current Journal Metrics dataset and links every title to its detailed record. Confirm current metrics, scope, indexing, access fees, and author instructions before submission.

Top oncology journals by impact factor

Compare the leading matched journals, then open the individual record for more detail.

Browse all related journals
#1
CA-A CANCER JOURNAL FOR CLINICIANS
ISSN 0007-9235United States
Oncology
Impact factor232.4
QuartileQ1
PublisherWiley
AccessOpen access
#2
Nature Reviews Clinical Oncology
ISSN 1759-4774United Kingdom
Cancer ResearchOncology
Impact factor82.2
QuartileQ1
PublisherNature Portfolio
AccessSubscription
#3
NATURE REVIEWS CANCER
ISSN 1474-175XUnited Kingdom
Cancer ResearchOncology
Impact factor66.8
QuartileQ1
PublisherNature Portfolio
AccessSubscription
#4
ANNALS OF ONCOLOGY
ISSN 0923-7534Netherlands
OncologyCancer Research
Impact factor65.4
QuartileQ1
PublisherElsevier BV
AccessSubscription
#5
CANCER CELL
ISSN 1535-6108Netherlands
OncologyCancer Research
Impact factor44.5
QuartileQ1
PublisherCell Press
AccessSubscription
#6
JOURNAL OF CLINICAL ONCOLOGY
ISSN 0732-183XUnited States
OncologyCancer Research
Impact factor41.9
QuartileQ1
PublisherLippincott Williams & Wilkins
AccessSubscription
#7
Impact factor40.4
QuartileQ1
PublisherNot listed
AccessCheck journal
#8
LANCET ONCOLOGY
ISSN 1470-2045United Kingdom
Oncology
Impact factor35.9
QuartileQ1
PublisherElsevier BV
AccessSubscription
#9
Impact factor33.9
QuartileQ1
PublisherNot listed
AccessCheck journal
#10
Cancer Discovery
ISSN 2159-8274United States
Cancer ResearchOncology
Impact factor33.3
QuartileQ1
PublisherAmerican Association for Cancer Research
AccessSubscription
#11
Impact factor28.5
QuartileQ1
PublisherNot listed
AccessCheck journal
#12
Impact factor24.9
QuartileQ1
PublisherNot listed
AccessCheck journal
#13
Journal of Thoracic Oncology
ISSN 1556-0864United States
Oncology
Impact factor20.8
QuartileQ1
PublisherElsevier BV
AccessSubscription
#14
JAMA Oncology
ISSN 2374-2437United States
OncologyCancer Research
Impact factor20.1
QuartileQ1
PublisherAmerican Medical Association
AccessSubscription
#15
Trends in Cancer
ISSN 2405-8033United States
Cancer ResearchOncology
Impact factor17.5
QuartileQ1
PublisherElsevier BV
AccessSubscription

How to choose a oncology journal

Scope before score

Confirm that the journal regularly publishes your condition, method, population, and article type before comparing metrics.

Match the reader

Choose the clinicians or researchers who should use the finding. A focused audience can be more valuable than a broader but less relevant one.

Check the evidence tier

Large trials, definitive cohorts, technical notes, case series, and laboratory studies often belong in different journals within the same specialty.

Verify current policies

Review indexing, open-access options, fees, reporting checklists, data policies, and author instructions on the journal's own website.

Major oncology publishing areas

Clinical oncology

Therapeutic trials, treatment sequencing, guidelines, comparative effectiveness, and patient outcomes.

Cancer biology and translational research

Tumor mechanisms, preclinical models, biomarkers, target validation, and early therapeutic development.

Hematologic malignancies

Leukemia, lymphoma, myeloma, transplantation, cellular therapy, and blood-cancer biology.

Prevention, epidemiology, and survivorship

Risk, screening, disparities, long-term outcomes, supportive care, and population-level cancer research.

Continue your journal search

Use the specialty ranking as a shortlist, then compare exact journal records and broader medical publishing guidance.

Frequently asked questions

How are the best oncology journals ranked on this page?

The table starts with journals matched to oncology topics in the Journal Metrics dataset, removes duplicate ISSNs, excludes records without a usable impact factor, and orders the remaining journals by impact factor. It is a metric-led shortlist, not a universal judgment of research quality or manuscript fit.

What is a good impact factor for a oncology journal?

A useful impact factor depends on the specialty and article type. Compare journals within the same clinical field and quartile rather than applying one threshold across medicine. Scope, readership, indexing, editorial standards, and access options remain important.

How should I choose among top oncology journals?

Start with scope and audience, then compare recent papers with your disease area, study design, population, and article type. Use impact factor and quartile to understand visibility, but confirm current author instructions and publication policies on the journal website.

How should authors compare clinical oncology and cancer biology journals?

Clinical oncology journals prioritize evidence that affects diagnosis, treatment, or patient outcomes. Cancer biology journals prioritize mechanistic depth and biological novelty. Translational studies should target the audience that benefits most from the paper’s primary conclusion.

MZ

Written by Dr. Meng Zhao

Physician-Scientist · Founder, LabCat AI

MD · Former Neurosurgeon · Medical AI Researcher

Dr. Meng Zhao is a former neurosurgeon turned medical-AI researcher. After years in the operating room, he moved into applied AI for clinical workflows and now leads LabCat AI, a medical-AI company working on decision support and research tooling for clinicians. He built Journal Metrics as a free resource for researchers who need reliable journal metrics without paid database subscriptions.

Related Articles

Canonical article: https://www.journalmetrics.org/blog/best-oncology-journals